Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients.

Molecular carcinogenesis - 1 Jun 2015

Woods Nicholas T, Monteiro Alvaro N, Thompson Zachary J, Amankwah Ernest K, Naas Nina, Haura Eric B, Beg Amer A, Schabath Matthew B

Abstract excerpt

Biomarkers based on germline DNA variations could have translational implications by identifying prognostic factors and sub-classifying patients to tailored, patient-specific treatment. To investigate the association between germline variations in interleukin (IL) genes and lung cancer outcomes, we genotyped 251 single nucleotide polymorphisms (SNPs) from 33 different IL genes in 651 non-small cell lung cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukins

Share to Lung Neoplasms

Share to Polymorphism, Single Nucleotide

Share to Recurrence

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 25597281
DOI: 10.1002/mc.22275
PMCID: PMC4475444

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients.PMID 25597281Read ↗

Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer.Semantic proximity Read ↗

Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients.Semantic proximity Read ↗

Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study.Semantic proximity Read ↗

TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer.Semantic proximity Read ↗

Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer.Semantic proximity Read ↗

Interleukin polymorphisms and protein levels associated with lung cancer susceptibility and phenotypes.Semantic proximity Read ↗

Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer.Semantic proximity Read ↗

Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women.Semantic proximity Read ↗

Host immune gene polymorphisms were associated with the prognosis of non-small-cell lung cancer in Chinese.Semantic proximity Read ↗

Causal association of circulating cytokines with the risk of lung cancer: a Mendelian randomization studySemantic proximity Read ↗

IL-18 and Lower Risk for Lung Cancer: Triangulated Evidence from Germline Predictions, Pre-Diagnostic Measurements, and Tumor ExpressionSemantic proximity Read ↗

A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.